Twist Bioscience Corporation
TWST
$120.64
-$4.65-3.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.19% | 17.77% | 18.59% | 20.32% | 22.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.19% | 17.77% | 18.59% | 20.32% | 22.72% |
| Cost of Revenue | 12.80% | 5.91% | 3.53% | 3.31% | 4.73% |
| Gross Profit | 25.78% | 31.32% | 37.30% | 43.24% | 49.12% |
| SG&A Expenses | 22.82% | 18.79% | 17.50% | 13.08% | 11.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.87% | 7.38% | 6.54% | 4.90% | 4.77% |
| Operating Income | 3.23% | 15.76% | 17.76% | 22.54% | 23.65% |
| Income Before Tax | -60.17% | 57.79% | 61.53% | 63.03% | 61.42% |
| Income Tax Expenses | 135.42% | 102.72% | 63.13% | 28.57% | -15.44% |
| Earnings from Continuing Operations | -60.49% | 57.48% | 61.19% | 62.79% | 61.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.49% | 57.48% | 61.19% | 62.79% | 61.33% |
| EBIT | 3.23% | 15.76% | 17.76% | 22.54% | 23.65% |
| EBITDA | 4.14% | 16.54% | 17.60% | 22.28% | 21.96% |
| EPS Basic | -53.87% | 59.40% | 62.54% | 63.81% | 62.11% |
| Normalized Basic EPS | 7.12% | 18.98% | 20.56% | 25.27% | 24.21% |
| EPS Diluted | -52.68% | 59.12% | 62.26% | 63.55% | 61.82% |
| Normalized Diluted EPS | 6.74% | 19.35% | 20.91% | 25.60% | 24.52% |
| Average Basic Shares Outstanding | 3.48% | 3.27% | 3.21% | 3.13% | 2.89% |
| Average Diluted Shares Outstanding | 2.97% | 3.76% | 3.71% | 3.63% | 3.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |